AmnioAMP-MP™
Allograft Patch
Harness the innate power of the human body
CellGenuity develops biologics designed to be used as a therapeutic agent. Formulated with our patented PūrAMP Process™, our products are used in a wide range of surgical and non-surgical applications.
AmnioAMP-MP™
Allograft Patch
AmnioAMP-MP™ is a membrane allograft that may be used as a therapeutic active barrier agent in numerous clinical applications. The membrane forms a protective covering over the wound to preserve tissue structure and biologic integrity. AmnioAMP-MP™ created with our proprietary PūrAMP Process™, offers mechanical protection and retains nutrient growth factors that are essential for signaling¹². The product undergoes active preservation of the extracellular matrix (ECM), regulatory proteins, and removal of blood contaminants via a proprietary PūrAMP Process™. AmnioAMP-MP™ is HCT/P compliant under section 361 of the Public Health Service Act according to 21 CFR Part 1271.10. This is regulated as human cell product-for homologous use only.
Advantages
E-Beam sterilization provides sterility assurance level (SAL) of 10-6.
Requires no up-front preparation before use.
Room temperature storage.
5 year shelf life.
Features
Natural Adherence – Adheres naturally to the patient’s tissues without need for sutures or other fixation.
Multi-directional – can be applied in either direction, with no orientation restrictions.
Stored at ambient temperature (50-86ºF/10-30ºC) until ready for use.
Ease of placement due to patent PūrAMP preservation technology.
- Coolen, N.A. et al. (2010). Comparison between human fetal and adult skin. Archives of Dermatological Research, 302(3), 4755.
- Rowlatt, U. (1979). Intrauterine wound healing in a 20-week fetus. Virchows Arch A Pathol Anat Histol, 381(3), 353361.
PHYSICIANS?
Join the other physicians that are finding the value in the “DAY-ONE” Process and products developed by CellGenuity. Click here to get connected with our team.
